Autologous stem cell transplantation in Hodgkin's disease

[11] Treatment of relapsed Hodgkin's disease [J]. BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (03): : 559 - 572

[12] THE PLACE OF HIGH-DOSE THERAPY WITH HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN RELAPSED AND REFRACTORY HODGKINS-DISEASE [J]. ANNALS OF ONCOLOGY, 1993, 4 : S21 - S27

[13] GRIBBEN JG, 1989, BLOOD, V73, P340

[14] High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML [J]. BRITISH JOURNAL OF CANCER, 1999, 81 (03) : 476 - 483

[15] Hasenclever D, 1996, ANN ONCOL, V7, P95

[16] High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices [J]. BLOOD, 1997, 89 (03) : 801 - 813

[17] Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group [J]. BLOOD, 2000, 96 (04) : 1280 - 1286

[18] Kottaridis PD, 2001, BLOOD, V98, p416A

[19] Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors [J]. BLOOD, 2000, 95 (05) : 1588 - 1593

[20] Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the autologous blood and marrow transplant registry [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 534 - 545

[11] Treatment of relapsed Hodgkin's disease [J]. BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (03): : 559 - 572

[12] THE PLACE OF HIGH-DOSE THERAPY WITH HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN RELAPSED AND REFRACTORY HODGKINS-DISEASE [J]. ANNALS OF ONCOLOGY, 1993, 4 : S21 - S27

[13] GRIBBEN JG, 1989, BLOOD, V73, P340

[14] High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML [J]. BRITISH JOURNAL OF CANCER, 1999, 81 (03) : 476 - 483

[15] Hasenclever D, 1996, ANN ONCOL, V7, P95

[16] High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices [J]. BLOOD, 1997, 89 (03) : 801 - 813

[17] Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group [J]. BLOOD, 2000, 96 (04) : 1280 - 1286

[18] Kottaridis PD, 2001, BLOOD, V98, p416A

[19] Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors [J]. BLOOD, 2000, 95 (05) : 1588 - 1593

[20] Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the autologous blood and marrow transplant registry [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 534 - 545